Male bowel cancer patients need more information about erectile dysfunction

Male bowel cancer patients are very likely to suffer from erectile dysfunction (ED) after treatment and yet the majority are not receiving adequate information about the condition, according to a study published in the British Medical Journal today.

Bowel cancer affects over 38,000 people every year in the UK with around half of patients surviving for more than five years after treatment. This figure is set to increase, says the study. Men are more likely to develop bowel cancer and many will suffer from ED after their treatment, say the authors, led by Professor Sue Wilson at the University of Birmingham.

The research team carried out a series of in-depth interviews with 28 patients in the West Midlands who had been treated for bowel cancer.

Most of the respondents experienced ED as a result of their treatment. Yet many had been uninformed and unprepared for it. Almost none were receiving adequate, effective and for the condition.

The interview results also reveal evidence of among – several respondents said their doctor or stoma nurse said ED would not matter to a patient of their age.

The authors conclude that information and treatment for ED are not routinely offered to male patients, as they are for prostate . They add that "the wide diversity of this patient group calls for greater coordination of care and consistent strategies to tackle unmet needs."

In an accompanying editorial, Larissa Temple, a colorectal surgeon at the Sloan-Kettering Institute in New York, says the study would have benefited from examples of men who had been successfully treated for erectile dysfunction so that effective systems could be identified.

Temple adds that the role of the partner merits analysis and that "this is probably an important component of sexual rehabilitation for men with colorectal cancer."

add to favorites email to friend print save as pdf

Related Stories

Cialis aids prostate cancer sex function

Oct 02, 2006

Dutch scientists say they have found a drug usually prescribed for erectile dysfunction in men increases the sexual function of prostate cancer survivors.

Bowel cancer rates fall among rich men only

Jun 01, 2011

(Medical Xpress) -- Men living in deprived areas now suffer from higher levels of bowel cancer than those from more affluent areas Glasgow academics have found.

New bowel cancer gene discovery

Nov 10, 2010

Targeting a specific genetic area linked to survival in patients with advanced bowel cancer could help increase survival rates by up to three months, new University research has found.

Recommended for you

Endogenous hormones improve breast cancer risk models

17 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

18 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments